Reference is made to the prospectus dated 7 October 2013 and the stock exchange announcement dated 8 October 2013 concerning the subsequent offering (the "Subsequent Offering") of up to 7,500,000 shares (the "Offer Shares") in Bionor Pharma ASA (the "Company") at a subscription price of NOK 2.75 per share. The Company reports that the Subsequent Offering was oversubscribed.
The subscription period in the Subsequent Offering ended on 22 October 2013 at 16.30 (CET). As a result of the Subsequent Offering, the Company will issue 7,500,000 Offer Shares at NOK 2.75 per share raising gross proceeds of approximately NOK 20.6 million.
All subscribers being allotted Offer Shares will receive a letter confirming the number of Offer Shares allotted to the subscriber and the corresponding amount to be paid. This letter is expected to be distributed on or about today's date.
To read more, please visit Bionor Pharma's website.